H2020
UNITE4TB
ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS
- Programme
- Horizon 2020
- Started
- Ends
- Duration
- 84 months
- Total cost
- EUR 185,000,000
- EU contribution
- EUR 92,500,000
- Participants
- 17 from 8 countries
- Topic
- H2020_IMI2-2020-20-03
- Grant agreement
- 101007873
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Janssen Pharmaceutica NV | BEBelgium | Participant | EUR 0 | PIC (1.00) |
| Lungs Europe | BEBelgium | Third party | Not stated | PIC (1.00) |
| Foundation for Innovative New Diagnostics | CHSwitzerland | Participant | EUR 1,135,540 | PIC (1.00) |
| Deutsches Zentrum Fur Infektionsforschung (Dzif) Ev | DEGermany | Participant | EUR 0 | PIC (1.00) |
| Klinikum der Ludwig-Maximilians-Universitat Munchen | DEGermany | Third party | Not stated | known name (0.97) |
| Otsuka Novel Products GmbH | DEGermany | Participant | EUR 0 | PIC (1.00) |
| Tuberculosis Network European Trialsgroup Ev | DEGermany | Participant | EUR 250,438 | PIC (1.00) |
| European Lung Foundation | GBUnited Kingdom | Participant | EUR 270,375 | PIC (1.00) |
| The Chancellor Masters and Scholars of the University of Cambridge | GBUnited Kingdom | Participant | EUR 241,930 | known name (0.95) |
| The University of Liverpool | GBUnited Kingdom | Participant | EUR 1,630,443 | PIC (1.00) |
| University College London | GBUnited Kingdom | Participant | EUR 9,333,906 | known name (0.95) |
| Critical Path Institute, Limited | IEIreland | Participant | EUR 2,387,091 | PIC (1.00) |
| Koninklijke Nederlandse Centrale Vereniging Tot Bestrijding der Tuberculose (Kncv) | NLNetherlands | Participant | EUR 1,573,524 | known name (0.95) |
| Task Research International B.V. | NLNetherlands | Third party | Not stated | PIC (1.00) |
| Global Alliance for Tb Drug Development Non Profit Organisation | USUnited States | Participant | EUR 1,393,765 | PIC (1.00) |
| The Regents of the University of California | USUnited States | Participant | EUR 1,500,100 | PIC (1.00) |
| Task Foundation Npc | ZASouth Africa | Participant | EUR 683,425 | PIC (1.00) |
Changes of the consortium
First seen on with 17 participants from 8 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.